AFTAGEL

Brand name authorized in: France Tunisia

Active ingredients

The drug AFTAGEL contains a combination of these active pharmaceutical ingredients (APIs):

1 Lidocaine
UNII V13007Z41A - LIDOCAINE HYDROCHLORIDE

Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane.

Read about Lidocaine
2 Zinc sulfate
UNII 89DS0H96TB - ZINC SULFATE, UNSPECIFIED FORM

Zinc sulfate is a source of zinc which is an essential trace element and involved in a number of body enzyme systems. Severe deficiency causes skin lesion, alopecia, diarrhoea, increased susceptibility to infections and failure to thrive in children.

Read about Zinc sulfate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Lidocaine, combinations
N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BB Amides
Discover more medicines within N01BB52

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
FR
Base de données publique des médicaments
Identifier(s): 60007960
TN
Direction de la Pharmacie et du Médicament
Identifier(s): 7623081